Trial · NCT07883252
Registered outcomes37
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 37
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | All cause 24-hour mortality | Mortality rate 24 hours after accident | Risk ratio (RR) for 24 hour all cause mortality |
| Secondary | Need for massive transfusion in the ED | Massive transfusion administered during care in the ED | |
| Secondary | Need for massive transfusion in the first 24 hours | Massive transfusion in the first 24 hours | |
| Secondary | Change in blood gas results during the first 24 hours | Change in results in the first 24 hours | |
| Secondary | Change in lab results during the first 24 hours | Change in lab results in the first 24 hours | |
| Secondary | Prehospital mortality | Patients that died before the arrived in the hospital | |
| Secondary | Mortality within the first hour | Patients that died within the first hour | |
| Secondary | Mortality in the first 6 hours | Patients that died within the first 6 hours after admission | |
| Secondary | 30 day mortality | Patients that died within the first 30 days | |
| Secondary | Cause of death | Cause of death during the follow-up period (30 days) | |
| Secondary | Length of stay in the hospital | Hospital admission period assessed up to 30 days | |
| Secondary | Length of stay in the ICU | Admission period in the ICU up to 30 days | |
| Secondary | Multiple organ dysfunction syndrome | MODS during the follow up period (up to 30 days) | MODS is defined as Sequential Organ Failure Assessment (SOFA) score \>=3 in \>=2 organ systems, yielding a minimum SOFA score of 6 |
| Secondary | Number of organ failure free days | Number of days free of advanced cardiovascular, respiratory and renal support during the follow up period (up to 30 days) | number of days free of advanced cardiovascular, respiratory and renal support |
| Secondary | Trauma induced coagulopathy (TIC) | Trauma induced coagulopathy will be assessed in prehospital samples (if available), at ED presentation and 6 hours after trauma | Trauma induced coagulopathy is defined as INR \>1.5 OR fibrinogen \<1.5 g/l OR PT \>18s OR FIBTEM A10 \<10 mm |
| Secondary | Pulmonary embolism | Pulmonary embolism during the follow up period (up to 30 days) | |
| Secondary | Deep venous thrombosis | Deep venous thrombosis during the follow up period (up to 30 days) | |
| Secondary | Adverse events related to transfusion | Adverse events related to transfusion during the follow up period (up to 30 days) | Adverse events: TRALI, TACO, hemolytic transfusion reaction, allergic reaction |
| Secondary | Number of blood products in the prehospital setting | Blood products transfused before admission in the hospital | |
| Secondary | Ratio of blood products in the prehospital setting | Ratio of blood products transfused before admission in the hospital |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07883252/registered